321 related articles for article (PubMed ID: 36510843)
21. Prognostic utility of gene therapy with herpes simplex virus thymidine kinase for patients with high-grade malignant gliomas: a systematic review and meta analysis.
Zhao F; Tian J; An L; Yang K
J Neurooncol; 2014 Jun; 118(2):239-246. PubMed ID: 24756350
[TBL] [Abstract][Full Text] [Related]
22. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study.
Jakacki RI; Cohen KJ; Buxton A; Krailo MD; Burger PC; Rosenblum MK; Brat DJ; Hamilton RL; Eckel SP; Zhou T; Lavey RS; Pollack IF
Neuro Oncol; 2016 Oct; 18(10):1442-50. PubMed ID: 27006176
[TBL] [Abstract][Full Text] [Related]
23. High-grade Glioma - A decade of care in Christchurch.
Yan SS; James ML; Kerstens P; de Lambert M; Robinson BA; Yi M
J Med Imaging Radiat Oncol; 2019 Oct; 63(5):665-673. PubMed ID: 31464076
[TBL] [Abstract][Full Text] [Related]
24. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
[TBL] [Abstract][Full Text] [Related]
25. Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma.
Kieran MW; Goumnerova L; Manley P; Chi SN; Marcus KJ; Manzanera AG; Polanco MLS; Guzik BW; Aguilar-Cordova E; Diaz-Montero CM; DiPatri AJ; Tomita T; Lulla R; Greenspan L; Aguilar LK; Goldman S
Neuro Oncol; 2019 Mar; 21(4):537-546. PubMed ID: 30883662
[TBL] [Abstract][Full Text] [Related]
26. Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment.
Franson A; McClellan BL; Varela ML; Comba A; Syed MF; Banerjee K; Zhu Z; Gonzalez N; Candolfi M; Lowenstein P; Castro MG
Front Med (Lausanne); 2022; 9():966458. PubMed ID: 36186781
[TBL] [Abstract][Full Text] [Related]
27. DNX-2401: an investigational drug for the treatment of recurrent glioblastoma.
Philbrick B; Adamson DC
Expert Opin Investig Drugs; 2019 Dec; 28(12):1041-1049. PubMed ID: 31726894
[No Abstract] [Full Text] [Related]
28. Experimental therapies: gene therapies and oncolytic viruses.
Hulou MM; Cho CF; Chiocca EA; Bjerkvig R
Handb Clin Neurol; 2016; 134():183-97. PubMed ID: 26948355
[TBL] [Abstract][Full Text] [Related]
29. Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma.
Philbrick BD; Adamson DC
Expert Opin Investig Drugs; 2019 Mar; 28(3):207-216. PubMed ID: 30676111
[TBL] [Abstract][Full Text] [Related]
30. Temozolomide for high grade glioma.
Hart MG; Garside R; Rogers G; Stein K; Grant R
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007415. PubMed ID: 23633341
[TBL] [Abstract][Full Text] [Related]
31. Craniospinal irradiation with concurrent temozolomide for primary metastatic pediatric high-grade or diffuse intrinsic pontine gliomas. A first report from the GPOH-HIT-HGG Study Group.
Müller K; Schlamann A; Guckenberger M; Warmuth-Metz M; Glück A; Pietschmann S; Wawer A; Kortmann RD; Kramm C; von Bueren AO
Strahlenther Onkol; 2014 Apr; 190(4):377-81. PubMed ID: 24638239
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy for high-grade glioma.
Iwami K; Natsume A; Wakabayashi T
Neurol Med Chir (Tokyo); 2010; 50(9):727-36. PubMed ID: 20885107
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas: A Randomized Clinical Trial.
Guo C; Yang Q; Xu P; Deng M; Jiang T; Cai L; Li J; Sai K; Xi S; Ouyang H; Liu M; Li X; Li Z; Ni X; Cao X; Li C; Wu S; Du X; Su J; Xue X; Wang Y; Li G; Qin Z; Yang H; Zhou T; Liu J; Hu X; Wang J; Jiang X; Lin F; Zhang X; Ke C; Lv X; Lv Y; Hu W; Zeng J; Chen Z; Zhong S; Wang H; Chen Y; Zhang J; Li D; Mou Y; Chen Z
JAMA Netw Open; 2023 Jan; 6(1):e2253285. PubMed ID: 36705923
[TBL] [Abstract][Full Text] [Related]
34. Analysis of factors influencing the access to concomitant chemo-radiotherapy in elderly patients with high grade gliomas: role of MMSE, age and tumor volume.
Di Cristofori A; Zarino B; Fanizzi C; Fornara GA; Bertani G; Rampini P; Carrabba G; Caroli M
J Neurooncol; 2017 Sep; 134(2):377-385. PubMed ID: 28685404
[TBL] [Abstract][Full Text] [Related]
35. Bevacizumab for the treatment of high-grade glioma: an update after phase III trials.
Khasraw M; Ameratunga M; Grommes C
Expert Opin Biol Ther; 2014 May; 14(5):729-40. PubMed ID: 24655021
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis.
Cao JX; Zhang XY; Liu JL; Li D; Li JL; Liu YS; Wang M; Xu BL; Wang HB; Wang ZX
PLoS One; 2014; 9(9):e107173. PubMed ID: 25215607
[TBL] [Abstract][Full Text] [Related]
37. Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945.
Eisenstat DD; Pollack IF; Demers A; Sapp MV; Lambert P; Weisfeld-Adams JD; Burger PC; Gilles F; Davis RL; Packer R; Boyett JM; Finlay JL
J Neurooncol; 2015 Feb; 121(3):573-81. PubMed ID: 25431150
[TBL] [Abstract][Full Text] [Related]
38. Risk stratification of pediatric high-grade glioma: a newly proposed prognostic score.
Muhammed A; Gaber MS; Elbeltagy M; El Hemaly A; Taha H; Refaat A; Zaghluol MS
Childs Nerv Syst; 2019 Dec; 35(12):2355-2362. PubMed ID: 31218465
[TBL] [Abstract][Full Text] [Related]
39. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
[TBL] [Abstract][Full Text] [Related]
40. [Gene Therapy and Viral Therapy for Malignant Glioma].
Kurozumi K; Koizumi S; Otani Y
No Shinkei Geka; 2021 May; 49(3):608-616. PubMed ID: 34092566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
